Contact Us

Launching Australia’s first RSV vaccine through earned media

/Overview

Cube led the branded consumer media announcement of Australia’s first respiratory syncytial virus (RSV) vaccine following its TGA registration for adults aged 60 and over. Through a carefully orchestrated earned media strategy, the campaign delivered widespread coverage across mainstream, health, and industry media. Expert commentary and clear, accessible messaging helped drive awareness of the vaccine’s availability and elevate public understanding of RSV.

/Challenge

Public awareness of RSV was low across all demographics, with existing knowledge largely centred on its impact in babies and young children. Our task was to shift the conversation, elevating RSV as a serious health concern for older adults and carving out space for it in a media landscape dominated by flu and COVID-19. The communication strategy needed to position the vaccine’s TGA registration as a major milestone and drive awareness of its availability, while ensuring messaging was both clear and credible for a broad public audience.

/Solution

Research revealed only half of Australians had heard of RSV, with minimal recognition of personal risk – highlighting the need for broad, urgent awareness. Our strategy aimed to establish RSV’s seriousness, differentiate it from flu/COVID, and saturate consumer, lifestyle and HCP media. We executed a tightly coordinated, multi-channel launch, embedding RSV into the national health agenda via exclusive media outreach, stakeholder-aligned materials, a dedicated TV filming opportunity, and close collaboration with government to ensure timely, accurate communication.

Impact

The campaign achieved significant cut-through across channels, successfully increasing awareness of RSV and the newly available vaccine:

Extensive media coverage

A total of 161 stories appeared across TV, online, print, radio, and social platforms, securing broad national reach and coverage diversity.

Strong message consistency

90% of coverage included the campaign’s key messages, ensuring clarity and impact across all outlets.

Positive public sentiment

All coverage sentiment was positive, reflecting the balanced, informative nature of the campaign’s messaging.

Expert endorsement

Expert commentary was included in 100% of coverage, reinforcing credibility and trustworthiness in media narratives.

Increased brand share of voice

The campaign drove a 35% increase in the brand’s share of voice within relevant health discussions.

Shift in public understanding

The campaign contributed to increased community awareness of RSV and its risks.

TESTIMONIAL

The Cube team have extensive experience in strategic communications to create impactful campaigns and events and demonstrate a real understanding of our organisation’s brand, objectives, and a broad range of partners and stakeholders. The team are dedicated to and skilful at crafting compelling narratives, securing high-profile media placements, attending to details and navigating through challenges in complex environments.

Kym Bramich
Head of Marketing & Communications Omico

Collaborating with Cube has been an immensely positive experience. Cube has demonstrated an excellent understanding of our goals and values, ensuring every aspect of the communications plan aligns with GSK’s mission. Their proactive approach in identifying opportunities and potential challenges has been a key factor in the success of our communications efforts. With meticulously planned execution of media engagements, the team’s professionalism, enthusiasm and creativity have exceeded our expectations, making them an indispensable business partner.

Helena Sfelagis
Senior Communications Manager, GSK

Working with Cube has been a remarkable experience. Like BeOne, they are a small team with big ambitions. Time and again, Cube has proven to be an effective, reliable, and responsible partner. They bring enormous energy, detail and innovation to every project and have helped BeOne achieve the highest goals and meet the tightest timelines. For every idea, they have a solution ready.

Louise Carter
Executive Director, Corporate Affairs Lead, JAPAC & New Markets, BeOne Medicines

Cube has partnered with Biocelect managing the arrival of a COVID-19 vaccine to Australia and New Zealand. The team has worked attentively and collaboratively with Biocelect and the US team in managing the challenging pandemic and vaccine dynamics as they evolve. They have applied their strategic communication, crisis management and media skills to be pre-emptive and agile in preparing for and managing local media and political commentary. They are responsive, professional, a pleasure to work with and, like Biocelect, hardworking!

Karl Herz
Managing Director, Biocelect (COVID-19 vaccine partner)

We brought Cube in as an external agency to support us with a communications initiative for one of our products in 2019. Now – I don’t know what I would do without them! They are no longer viewed as ‘the agency’, but integral to the Novartis team – as partners and strategic advisors. Now working across multiple portfolios, Cube consistently bring their high-level strategic insight, laser focus for detail, and deep expertise across the entire gamut of communications. I would highly recommend Cube to anyone looking for a nimble yet well-rounded agency partner.

Andi Bennett
Communications/Patient Relations, Novartis

In our dealings with Cube over the past 3 years, we have found the team to be very professional, enthusiastic and helpful. Their high level of honesty and integrity means we have full trust in their recommendations and their approach to meeting our needs. Their strategic thinking and recommended plans are always well-considered. They have done high level strategic work for us and developed detailed plans as well as a new service launch. They have been very responsive to our needs and we would not hesitate to engage them again!

Brenda Davy
Business Development Director, CHPA

MS Australia engaged Cube for two critically important campaigns in the first half of 2022. Their strategic planning and implementation was first-class, and the very significant results has greatly assisted our advocacy work.

For our landmark MS Nurse Care Report launched in Tasmania, Cube crafted a communications plan focussed on local media which as planned, fanned out to outlets across the country. The coverage was astounding and helped raise vital awareness about the role of the MS Nurse in the patient care journey and the need for more funding.

Cube also expertly project-managed a market research study and national communications plan for our Employment & Workplace Survey, launched on World MS Day. This campaign garnered significant media coverage and spotlighted critical issues around employment and MS.

We cannot thank Cube enough for their friendliness, support and compassion for people living with multiple sclerosis.

Rohan Greenland
CEO, MS Australia

More Case Studies

Launching Australia’s first RSV vaccine through earned media

Cube led the branded consumer media announcement of Australia’s first respiratory syncytial virus (RSV) vaccine following its TGA registration for adults aged 60 and over. Through a carefully orchestrated earned media strategy, the campaign delivered widespread coverage across mainstream, health, and industry media. Expert commentary and clear, accessible messaging helped drive awareness of the vaccine’s availability and elevate public understanding of RSV.

Read More

Brand identity and digital launch for a biotech manufacturing facility

Cube was engaged to develop and launch the brand for VVMF (Viral Vector Manufacturing Facility) as it entered a new phase of commercialisation. A local biotech manufacturing start-up, VVMF was preparing to establish itself as a leading viral vector CDMO, supporting growing demand for advanced cell and gene therapies across Australia and the APAC region.

Cube’s remit extended beyond visual identity to include strategic messaging, digital presence and launch materials designed to position VVMF as a credible, future-facing partner for industry, research and commercial collaborators.

Read More

Earned media campaign addressing gender bias in STEMM

Women make up just 27% of Australia’s STEMM workforce and earn 23.5% less than their male counterparts. To address this gender disparity, particularly on platforms like Wikipedia, Cube launched a dynamic media campaign in collaboration with Franklin Women’s Wikipedia ‘Edit-a-thon’ events held in Sydney and Canberra. The initiative aimed to celebrate and elevate the visibility of women in STEMM fields.

Read More

Behaviour-change campaign to increase flu vaccination in high-risk groups

With flu vaccination rates being only 30% for high-risk groups in 2019, Cube set out to tackle the worst flu season on record. Powered by a creative social campaign, utilising consumer and trade media experts, we introduced a new motivator to persuade high risk groups to seek vaccination and protect themselves from influenza and heart attack.

Read More

AdCheck – Improving advertising compliance in consumer health

From 1 July 2020, mandatory pre-approvals of therapeutic goods consumer advertising ended, moving to a new self-regulatory process. Consumer Health Products Australia (CHP Australia) stepped into support – offering a new independent compliance service run by dedicated experts to support with compliance needs, training, and advice.

Read More

Public health campaign promoting early melanoma detection

Melanoma is a significant health concern, particularly in rural and regional Australia. Despite the higher incidence rates in these areas, many individuals lack awareness of the disease and available support services. The Self-Skin Checks, No Regrets campaign aimed to address this gap by providing tailored information and resources to encourage regular skin checks and early intervention.

Read More

A paradigm shift in surgical robotics in Australia

Cube supported Life Healthcare with an earned media campaign to announce the arrival of the Versius Surgical Robotic System in Australia and its first installation at Macquarie University Hospital, Sydney – making Australia one of five countries in the world to have access to the technology.

Read More